Ironwood Pharmaceuticals
IRWD
#6948
Rank
โ‚ฌ0.48 B
Marketcap
2,99ย โ‚ฌ
Share price
-6.70%
Change (1 day)
-7.94%
Change (1 year)

Revenue for Ironwood Pharmaceuticals (IRWD)

Revenue in 2025 (TTM): โ‚ฌ0.30 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.29 Billion. In 2024 the company made a revenue of โ‚ฌ0.33 Billion a decrease over the revenue in the year 2023 that were of โ‚ฌ0.40 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ironwood Pharmaceuticals from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.30 B-10.76%
2024 โ‚ฌ0.33 B-15.68%
2023 โ‚ฌ0.40 B4.63%
2022 โ‚ฌ0.38 B4.77%
2021 โ‚ฌ0.36 B15.36%
2020 โ‚ฌ0.31 B-17.19%
2019 โ‚ฌ0.38 B26.21%
2018 โ‚ฌ0.30 B21.89%
2017 โ‚ฌ0.24 B-4.55%
2016 โ‚ฌ0.26 B90.42%
2015 โ‚ฌ0.13 B117.64%
2014 โ‚ฌ62.84 M279.33%
2013 โ‚ฌ16.56 M-85.41%
2012 โ‚ฌ0.11 B123.93%
2011 โ‚ฌ50.72 M53.83%
2010 โ‚ฌ32.97 M32.32%
2009 โ‚ฌ24.91 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Nektar Therapeutics
NKTR
โ‚ฌ53.76 M-81.53%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ49.91 B 17,047.27%๐Ÿ‡ฌ๐Ÿ‡ง UK